DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /GPCR & G Protein TargetsGPCR & G Protein Targets
  5. /LPL ReceptorLPL Receptor
  6. /Etrasimod ArginineEtrasimod Arginine
Chemical structure of CAS 1206123-97-8

Etrasimod Arginine

In Stock•Starting at $154 for 100 mg•Purity ≥ 95%
CAS No.1206123-97-8
MDL No.N/A
MFC32H40F3N5O5
MW631.70
InChI KeyGVPVVOSNDUAUKM-BPGOJFKZSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg95%+$154In Stock
250 mg95%+$231In Stock
1 g95%+$572In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Etrasimod arginine is an organoammonium salt formed by combining etrasimod with one molar equivalent of L-arginine. It is a sphingosine 1-phosphate receptor modulator approved for treating moderately to severely active ulcerative colitis in adults. It functions as an anti-inflammatory drug, immunosuppressive agent, and sphingosine-1-phosphate receptor 1 antagonist, containing L-argininium(1+) and etrasimod(1-).

CAS No.1206123-97-8
Product NameEtrasimod Arginine
Heavy Atom Count45Rotatable Bond Count11
Atom Stereo Count2Bond Stereo Count0
HBA5HBD6
TPSA190.040 ŲCharge0
Exact Mass631.29815Complexity1527.36
pKa0.032XLogP5.380

Documentation

Similar Products

  • Etrasimod

    CAS No.1206123-37-6

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact